iBio: stockholders approve plan amendment and increase authorized shares

What happened

• iBio reported that at its 2026 annual meeting on Oct 14, 2026, its stockholders approved Amendment No. 1 to the iBio, Inc. 2023 Omnibus Incentive Plan (the “Plan Amendment”).
• The filing states that on Oct 16, 2026 the company filed a Certificate of Amendment with the Delaware Secretary of State to increase authorized shares of common stock from 275,000,000 shares to 500,000,000 shares, which became effective upon filing.
• The filing says a description of the Plan, as amended by the Plan Amendment, is set forth in the company’s definitive proxy statement on Schedule 14A filed Sep 4, 2026, which is incorporated by reference.

Key details

• Plan Amendment mechanics: on Jan 1, 2027; Jan 1, 2028; and Jan 1, 2029, the Plan will increase by: (i) 5% of shares of common stock outstanding on Dec 31 of the preceding calendar year, plus (ii) 3% of shares issuable upon exercise of pre-funded warrants outstanding on Dec 31 of the preceding calendar year. On Jan 1, 2030; Jan 1, 2031; Jan 1, 2032; and Jan 1, 2033, the Plan will increase by 5% of total shares of common stock outstanding on Dec 31 of the preceding calendar year, subject to the board acting before Jan 1 to set a lesser increase.
• Vote on the Plan Amendment: Votes for 45,730,093; votes against 2,052,563; abstentions 461,608; broker non-votes 0.
• Authorized share increase: amended authorized common stock from 275,000,000 to 500,000,000 shares; Certificate of Amendment filed Oct 16, 2026 and became effective upon filing.

Why it may matter

• Items reported: Item 5.02 (departure of directors or certain officers; election of directors) as used in the filing to report the Plan Amendment, Item 5.03 (amendments to articles of incorporation or bylaws) reporting the voting results, and Item 5.07 (submission of matters to a vote of security holders) reporting the authorized share increase and filing.
• The filing states these corporate actions were approved by the company’s stockholders and that the Certificate of Amendment became effective upon filing with the Delaware Secretary of State. A filing does not show why the insider traded or why the company acted.